These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27958884)
1. In Vivo Evaluation and Imaging of a Bilayered Self-Assembled Skin Substitute Using a Decellularized Dermal Matrix Grafted on Mice. Beaudoin Cloutier C; Goyer B; Perron C; Guignard R; Larouche D; Moulin VJ; Germain L; Gauvin R; Auger FA Tissue Eng Part A; 2017 Apr; 23(7-8):313-322. PubMed ID: 27958884 [TBL] [Abstract][Full Text] [Related]
2. Production of a Bilayered Self-Assembled Skin Substitute Using a Tissue-Engineered Acellular Dermal Matrix. Beaudoin Cloutier C; Guignard R; Bernard G; Gauvin R; Larouche D; Lavoie A; Lacroix D; Moulin VJ; Germain L; Auger FA Tissue Eng Part C Methods; 2015 Dec; 21(12):1297-305. PubMed ID: 26414947 [TBL] [Abstract][Full Text] [Related]
3. Biofabrication and preclinical evaluation of a large-sized human self-assembled skin substitute. Kawecki F; Mayrand D; Ayoub A; Attiogbe É; Germain L; Auger FA; Moulin VJ Biomed Mater; 2021 Feb; 16(2):025023. PubMed ID: 33007772 [TBL] [Abstract][Full Text] [Related]
4. Epithelial and stromal developmental patterns in a novel substitute of the human skin generated with fibrin-agarose biomaterials. Carriel V; Garzón I; Jiménez JM; Oliveira AC; Arias-Santiago S; Campos A; Sánchez-Quevedo MC; Alaminos M Cells Tissues Organs; 2012; 196(1):1-12. PubMed ID: 22146480 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of dermal-epidermal skin equivalents ('composite-skin') of human keratinocytes in a collagen-glycosaminoglycan matrix(Integra artificial skin). Kremer M; Lang E; Berger AC Br J Plast Surg; 2000 Sep; 53(6):459-65. PubMed ID: 10927672 [TBL] [Abstract][Full Text] [Related]
6. A preexisting microvascular network benefits in vivo revascularization of a microvascularized tissue-engineered skin substitute. Gibot L; Galbraith T; Huot J; Auger FA Tissue Eng Part A; 2010 Oct; 16(10):3199-206. PubMed ID: 20528673 [TBL] [Abstract][Full Text] [Related]
7. Engineered human skin substitutes undergo large-scale genomic reprogramming and normal skin-like maturation after transplantation to athymic mice. Klingenberg JM; McFarland KL; Friedman AJ; Boyce ST; Aronow BJ; Supp DM J Invest Dermatol; 2010 Feb; 130(2):587-601. PubMed ID: 19798058 [TBL] [Abstract][Full Text] [Related]
8. Improved Methods to Produce Tissue-Engineered Skin Substitutes Suitable for the Permanent Closure of Full-Thickness Skin Injuries. Larouche D; Cantin-Warren L; Desgagné M; Guignard R; Martel I; Ayoub A; Lavoie A; Gauvin R; Auger FA; Moulin VJ; Germain L Biores Open Access; 2016; 5(1):320-329. PubMed ID: 27872793 [TBL] [Abstract][Full Text] [Related]
10. Speeding up the production of clinical-grade skin substitutes using off-the-shelf decellularized self-assembled dermal matrices. Magne B; Demers A; Savard É; Lemire-Rondeau M; Veillette N; Pruneau V; Guignard R; Morissette A; Larouche D; Auger FA; Germain L Acta Biomater; 2023 Sep; 167():249-259. PubMed ID: 37285897 [TBL] [Abstract][Full Text] [Related]
11. IFATS collection: Using human adipose-derived stem/stromal cells for the production of new skin substitutes. Trottier V; Marceau-Fortier G; Germain L; Vincent C; Fradette J Stem Cells; 2008 Oct; 26(10):2713-23. PubMed ID: 18617689 [TBL] [Abstract][Full Text] [Related]
13. Biomimetic bilayered gelatin-chondroitin 6 sulfate-hyaluronic acid biopolymer as a scaffold for skin equivalent tissue engineering. Wang TW; Wu HC; Huang YC; Sun JS; Lin FH Artif Organs; 2006 Mar; 30(3):141-9. PubMed ID: 16480388 [TBL] [Abstract][Full Text] [Related]
14. A new dermal equivalent: the use of dermal fibroblast culture alone without exogenous materials. Lee DY; Lee JH; Yang JM; Lee ES; Park KH; Mun GH J Dermatol Sci; 2006 Aug; 43(2):95-104. PubMed ID: 16687242 [TBL] [Abstract][Full Text] [Related]
15. The effect of gelatin-chondroitin sulfate-hyaluronic acid skin substitute on wound healing in SCID mice. Wang TW; Sun JS; Wu HC; Tsuang YH; Wang WH; Lin FH Biomaterials; 2006 Nov; 27(33):5689-97. PubMed ID: 16908060 [TBL] [Abstract][Full Text] [Related]
16. Full-thickness skin wound healing using autologous keratinocytes and dermal fibroblasts with fibrin: bilayered versus single-layered substitute. Idrus RB; Rameli MA; Low KC; Law JX; Chua KH; Latiff MB; Saim AB Adv Skin Wound Care; 2014 Apr; 27(4):171-80. PubMed ID: 24637651 [TBL] [Abstract][Full Text] [Related]
17. Rapid creation of skin substitutes from human skin cells and biomimetic nanofibers for acute full-thickness wound repair. Mahjour SB; Fu X; Yang X; Fong J; Sefat F; Wang H Burns; 2015 Dec; 41(8):1764-1774. PubMed ID: 26187057 [TBL] [Abstract][Full Text] [Related]
18. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Llames SG; Del Rio M; Larcher F; García E; García M; Escamez MJ; Jorcano JL; Holguín P; Meana A Transplantation; 2004 Feb; 77(3):350-5. PubMed ID: 14966407 [TBL] [Abstract][Full Text] [Related]
19. Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes. Boyce ST; Supp AP; Swope VB; Warden GD J Invest Dermatol; 2002 Apr; 118(4):565-72. PubMed ID: 11918700 [TBL] [Abstract][Full Text] [Related]
20. Induction of vascular endothelial growth factor by fibrin as a dermal substrate for cultured skin substitute. Hojo M; Inokuchi S; Kidokoro M; Fukuyama N; Tanaka E; Tsuji C; Miyasaka M; Tanino R; Nakazawa H Plast Reconstr Surg; 2003 Apr; 111(5):1638-45. PubMed ID: 12655209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]